Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) gapped up before the market opened on Thursday . The stock had previously closed at $9.03, but opened at $9.25. Teladoc Health shares last traded at $9.59, with a volume of 2,357,100 shares trading hands.
Analyst Ratings Changes
Several research analysts have recently weighed in on the company. The Goldman Sachs Group lowered their target price on Teladoc Health from $16.00 to $13.00 and set a "buy" rating on the stock in a report on Monday, March 3rd. Oppenheimer lowered their price objective on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a research note on Friday, January 24th. Bank of America raised their target price on Teladoc Health from $11.50 to $13.50 and gave the stock a "neutral" rating in a research note on Wednesday, February 12th. Royal Bank of Canada lifted their price target on Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. Finally, Piper Sandler dropped their price objective on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating for the company in a report on Thursday, February 27th. Eleven equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $11.26.
Read Our Latest Report on Teladoc Health
Teladoc Health Trading Down 2.4 %
The company has a 50 day simple moving average of $10.61 and a 200 day simple moving average of $9.67. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $1.55 billion, a PE ratio of -1.55 and a beta of 1.27.
Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.49 million during the quarter, compared to analysts' expectations of $639.44 million. Analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Teladoc Health
Institutional investors and hedge funds have recently bought and sold shares of the stock. Versant Capital Management Inc raised its holdings in shares of Teladoc Health by 313.8% in the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock worth $29,000 after acquiring an additional 2,441 shares during the last quarter. Whipplewood Advisors LLC acquired a new position in Teladoc Health in the 4th quarter valued at about $29,000. Lindbrook Capital LLC lifted its holdings in Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after purchasing an additional 1,612 shares in the last quarter. Sterling Capital Management LLC boosted its stake in shares of Teladoc Health by 776.7% during the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock worth $42,000 after purchasing an additional 4,101 shares during the last quarter. Finally, Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of Teladoc Health during the fourth quarter worth about $60,000. Hedge funds and other institutional investors own 76.82% of the company's stock.
Teladoc Health Company Profile
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Articles
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.